Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03019588 |
|---|---|
| Brief Title: | Efficacy and Safety Study of Pembrolizumab (MK-3475) Versus Paclitaxel in Asian Participants With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-line Therapy With Platinum and Fluoropyrimidine (MK-3475-063/KEYNOTE-063) |
| First Submitted : | January 11, 2017 |
| First Submitted that Met QC Criteria : | January 11, 2017 |
| First Posted : | January 12, 2017 (Estimate) |
| Results First Submitted : | June 21, 2022 |
| Results First Submitted that Met QC Criteria : | June 21, 2022 |
| Results First Posted : | March 30, 2023 |
| Last Update Submitted that Met QC Criteria : | June 21, 2022 |
| Last Update Posted : | March 30, 2023 |